Evidence map›Paper›PMID 26990380›Full record

ArticleNano letters2016

High-Throughput Mechanobiology Screening Platform Using Micro- and Nanotopography.

Junqiang Hu, Alexander A Gondarenko, Alex P Dang, Keenan T Bashour, Roddy S O'Connor, Sunwoo Lee, Anastasia Liapis, Saba Ghassemi, Michael C Milone, Michael P Sheetz and 3 more

Abstract read
In one paragraph

Article in Nano letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. The CAR T-Cell Mechanoimmunology at a Glance.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. T cell activation and immune synapse organization respond to the microscale mechanics of structured surfaces.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Junqiang Hu
Alexander A Gondarenko
Alex P Dang
Keenan T Bashour
Roddy S O'ConnorDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania 19104, United States.
Sunwoo Lee
Anastasia LiapisDepartment of Pathology, New York University School of Medicine , New York, New York 10016, United States.
Saba GhassemiDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania 19104, United States.
Michael C MiloneDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania 19104, United States.
Michael P Sheetz
Michael L DustinNuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, The University of Oxford , Oxford, OX3 7FY, U.K.
Lance C Kam
James C Hone
University of Pennsylvania · USNew York University · US

Funding

Nanomedicine development center for mechanobiologyPN2EY016586 · NEI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DUSTIN, MICHAEL LORAN · 2005 to 2014
$23.0M
Tropomyosin and tyrosine kinases in mechanics of cancerR01GM113022 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SHEETZ, MICHAEL PATRICK · 2015 to 2018
$1.2M
Analyses of 120nm Local Contractions Linked to Rigidity SensingR01GM100282 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI HONE, JAMES C · 2012 to 2015
$1.2M
NEI NIH HHS PN2 EY016586NEI NIH HHS PN2EY016586NIGMS NIH HHS R01 GM100282NIGMS NIH HHS R01 GM113022
6 · The paper itself

Abstract

We herein demonstrate the first 96-well plate platform to screen effects of micro- and nanotopographies on cell growth and proliferation. Existing high-throughput platforms test a limited number of factors and are not fully compatible with multiple types of testing and assays. This platform is compatible with high-throughput liquid handling, high-resolution imaging, and all multiwell plate-based instrumentation. We use the platform to screen for topographies and drug-topography combinations that have short- and long-term effects on T cell activation and proliferation. We coated nanofabricated "trench-grid" surfaces with anti-CD3 and anti-CD28 antibodies to activate T cells and assayed for interleukin 2 (IL-2) cytokine production. IL-2 secretion was enhanced at 200 nm trench width and >2.3 μm grating pitch; however, the secretion was suppressed at 100 nm width and <0.5 μm pitch. The enhancement on 200 nm grid trench was further amplified with the addition of blebbistatin to reduce contractility. The 200 nm grid pattern was found to triple the number of T cells in long-term expansion, a result with direct clinical applicability in adoptive immunotherapy.

Indexed as

Cell Culture TechniquesLymphocyte ActivationNanotechnologyT-LymphocytesAnimalsHumansInterleukin-2IL2 protein, humanInterleukin-2High-throughput screeninginterleukin-2Lcklong-term expansionnanotechnologyT cell

Identifiers

PMID26990380
PMCPMC5403373
OpenAlexW2298994819

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.